Naviscan nets CE mark PET-guided applications

Naviscan has obtained CE mark approval for its high-resolution PET scanner and PET-guided biopsy accessory. The breast application of the scanner is Positron Emission Mammography (PEM).

The San Diego-based company has expanded its distribution into 13 European countries and has received orders in Germany and Switzerland.

The scanner with PET-guided biopsy system uses PET technology to produce tomographic images that allow physicians to visualize breast tumors with a resolution of 1.6 mm.

Around the web

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.